ATP9A and follicular lymphoma: An under-expression of ATP9A was reported in relapsed follicular lymphoma patients upon the analysis of 38 differentially expressed ion channels and transporter genes identifying ATP9A as one of the novel lymphoma biomarkers related to excitability and metabolic pathways, with particular relevance for drug-resistant, relapsed follicular lymphoma [56].